第四十八章 醫院藥品檢驗
...。加蒸餾水稀釋可又發生橙色沉澱。 Bi3++3KI→BiI3↓+3K+ Bi3++KI→KbiI4 繼續加蒸餾水稀釋,絡合鹽即分解,先形成碘化鉍而生成橙色的氧碘化鉍沉澱物。 KbiI4+Ho→BiOI↓+2HI+KI 如Bi3+...
醫源資料庫;醫源圖書館;教材類;醫院藥學AdenoviralGeneTransferofFGF-5toHibernatingMyocardiumImprovesFunctionandStimulatesMyocytestoHypertrophyandReentertheCellCycle
....2±0.92einuntreated,P0.001).Myocytesintheproliferativephaseofthecellcycle(Ki-67staining)increased7-foldafterAdvFGF-5(2,904±405versus409±233per106myocytenucleiinuntreated,P0.05).Myocytenucleiinthemitoticphase(phosphorylatedhistoneH3staining)alsoincreasedafterAdvFGF-5(127±24versus35±13per106myocy...
醫源資料庫;在線期刊;循環研究雜誌;2005年第95卷第4期EnrichedEnvironmentIncreasesNeuralStem/ProgenitorCellProliferationandNeurogenesisintheSubventricularZoneofStroke-LesionedAdultRats
...alprecursorsinthesubventricularzonewerestudiedwithcellspecificmarkerssuchasKi67andphosphorylatedhistoneH3(cellproliferation),Sox-2(neuralstem/progenitorcells),bromodeoxyuridine(slowlycycling,nonmigratoryputativeneuralstemcells),anddoublecortin(newbornimmatureneurons).Results—Proliferatingcellsinth...
醫源資料庫;在線期刊;中風學雜誌;2005年第36卷第6期AntihypertensiveEffectsofthePutativeT-TypeCalciumChannelAntagonistMibefradilAreMediatedbytheL-TypeCalciumChannelCav1.2
...verL-typechannels)and,thus,theusabilityofmibefradilasaT-typeCa2+channelblockingagentforfunctionalstudiesinthecardiovascularsystem.9,10Combinedwiththeantihypertensiveanddirectvasodilatingeffectsmibefradilonisolatedvessels,11eC14asignificantbodyofevidencehasbeenaccumulatedsuggestingthepresenceandfunct...
醫源資料庫;在線期刊;循環研究雜誌;2006年第96卷第1期Fifty(orMore)WaystoLeaveYourPlatelets(inaThrombus)
...atplateletsexpressatleastoneoftheknownreceptorsforGas-6,thereceptortyrosinekinase,Mer.1Accordingtotheirobservations,deletionofthegeneencodingMerinmicedoesnotproduceanovertbleedingphenotypeorevenprolongthebleedingtime,butitdoesinhibitplateletaggregation,diminishthethromboticresponsetovascularinjury,a...
醫源資料庫;在線期刊;動脈硬化血栓血管生物學雜誌;2004年第24卷第6期無公害中藥材杭白芍產地環境
...定火焰原子吸收分光光度法GB/T17140土壤質量鉛、鎘的測定KI—MIBK萃取火焰原子吸收分光光度法GB/T17141土壤質量鉛、鎘的測定石墨爐原子吸收分光光度法NY/T395農田土壤環境質量監測技術規範NY/T396農用水源環境質量監測技術規範NY/T...
藥品天地;專業藥學;中藥大全;中藥材生產技術及質量管理;藥用植物栽培管理乳腺神經內分泌癌1例並文獻複習
.../10HPF。免疫組化ER、PR、CgA、CK7均陽性,40%腫瘤細胞呈Ki-67陽性。結論:乳腺大細胞神經內分泌癌與肺大細胞神經內分泌癌細胞形態學相似。其組織學起源支持乳腺幹細胞來源學說。乳腺神經內分泌癌發病有年輕化趨勢,本病...
醫源資料庫;在線期刊;中國民康醫學;2008年第20卷第19期Lithiumtreatmentinducesamarkedproliferationofprimarilyprincipalcellsinratkidneyinnermedullarycollectingduct
...fintercalatedcellsinparallelwithadecreaseinthefractionofprincipalcellsinthekidneycollectingduct(ChristensenBM,MarplesD,KimYH,WangW,FrøkiærJ,andNielsenS.AmJPhysiolCellPhysiol286:C952-C964,2004;KimYH,KwonTH,ChristensenBM,NielsenJ,WallSM,MadsenKM,FrøkiærJ,andNielsenS.AmJPhysio...
醫源資料庫;在線期刊;美國生理學雜誌;2006年第289卷第7期胃特殊癌-賁門癌120例的相關免疫組化研究
...triccardiaisunusualintissuesourceandtheprognosismaybedifferentalthoughitisakindofgastriccarcinoma.【Keywords】Gastriccarcinoma;Immunohistochemistry賁門癌的發生與食管癌類似,有較明顯的地域性,並且在食管癌的高發人羣中,賁門癌的發病率也高。一般認爲賁門...
醫源資料庫;在線期刊;中華中西醫雜誌;2008年第9卷第3期AldosteroneandAngiotensinIISynergisticallyInduceMitogenicResponseinVascularSmoothMuscleCells
...blocker,olmesartan,amineralocorticoidreceptorantagonist,spironolactone,anMEKinhibitor,PD98059,oranEGFreceptortyrosinekinaseinhibitor,AG1478.TreatmentwithAldotogetherwithAngII,evenatnoneffectivedoses,respectively,synergisticallyincreasedextracellularsignal-regulatedkinase(ERK)activation,reaching2peak...
醫源資料庫;在線期刊;循環研究雜誌;2005年第95卷第9期